首页> 外文期刊>Analytical and Bioanalytical Chemistry >Kinetic analyses and performance of a colloidal magnetic nanoparticle based immunoassay dedicated to allergy diagnosis
【24h】

Kinetic analyses and performance of a colloidal magnetic nanoparticle based immunoassay dedicated to allergy diagnosis

机译:用于过敏诊断的基于胶体磁性纳米粒子的免疫测定的动力学分析和性能

获取原文
获取原文并翻译 | 示例
           

摘要

In this paper, we demonstrate the possibility to use magnetic nanoparticles as immunosupports for allergy diagnosis. Most immunoassays used for immunosupports and clinical diagnosis are based on a heterogeneous solid-phase system and suffer from mass-transfer limitation. The nanoparticles’ colloidal behavior and magnetic properties bring the advantages of homogeneous immunoassay, i.e., species diffusion, and of heterogeneous immunoassay, i.e., easy separation of the immunocomplex and free forms, as well as analyte preconcentration. We thus developed a colloidal, non-competitive, indirect immunoassay using magnetic core–shell nanoparticles (MCSNP) as immunosupports. The feasibility of such an immunoassay was first demonstrated with a model antibody and described by comparing the immunocapture kinetics using macro (standard microtiter plate), micro (microparticles) and nanosupports (MCSNP). The influence of the nanosupport properties (surface chemistry, antigen density) and of the medium (ionic strength, counter ion nature) on the immunocapture efficiency and specificity was then investigated. The performances of this original MCSNP-based immunoassay were compared with a gold standard enzyme-linked immunosorbent assay (ELISA) using a microtiter plate. The capture rate of target IgG was accelerated 200-fold and a tenfold lower limit of detection was achieved. Finally, the MCSNP-based immunoassay was successfully applied to the detection of specific IgE from milk-allergic patient’s sera with a lower LOD and a good agreement (CV < 6%) with the microtiter plate, confirming the great potential of this analytical platform in the field of immunodiagnosis.
机译:在本文中,我们证明了使用磁性纳米颗粒作为过敏性诊断的免疫支持的可能性。用于免疫支持和临床诊断的大多数免疫分析都是基于异质固相系统,并且存在传质受限的问题。纳米粒子的胶体行为和磁性能带来了均相免疫测定(即物种扩散)和异质免疫测定(即,免疫复合物和游离形式易于分离以及分析物预浓缩)的优势。因此,我们开发了一种胶体,非竞争性间接免疫测定方法,使用核壳纳米粒子(MCSNP)作为免疫支持物。首先用模型抗体证明了这种免疫测定的可行性,并通过比较使用宏观(标准微量滴定板),微粒(微粒)和纳米载体(MCSNP)的免疫捕获动力学来进行描述。然后研究了纳米载体性质(表面化学,抗原密度)和介质(离子强度,抗离子性质)对免疫捕获效率和特异性的影响。使用微量滴定板将这种原始的基于MCSNP的免疫测定与金标准酶联免疫吸附测定(ELISA)的性能进行了比较。目标IgG的捕获率提高了200倍,检测下限降低了10倍。最终,基于MCSNP的免疫测定法成功地用于检测牛奶过敏患者血清中的特异性IgE,其LOD较低,并且与微量滴定板吻合良好(CV <6%),从而证实了该分析平台的巨大潜力免疫诊断领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号